BARABE TIMOTHY C
SEC Form 4 insider trading activity
BARABE TIMOTHY C has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including HTFL, RNAC, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 24, 2026.
On the most recent filing, BARABE TIMOTHY C is listed as Director at Cartesian Therapeutics, Inc. Inside the rolling window, BARABE TIMOTHY C reported 1 open-market purchase totaling $206K in RNAC and no open-market sales.
Companies traded
Other insiders at HTFL
Insider Buying
$206K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BARABE TIMOTHY C made?
BARABE TIMOTHY C has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including HTFL, RNAC since 2025.
Which companies does BARABE TIMOTHY C trade?
BARABE TIMOTHY C has filed SEC Form 4 disclosures for 2 companies, including HTFL, RNAC.
When was BARABE TIMOTHY C's most recent SEC Form 4 filing?
BARABE TIMOTHY C's most recent SEC Form 4 filing on Tracefour is dated Jul 24, 2026.
What is BARABE TIMOTHY C's total buy and sell value in the current window?
Inside the rolling retention window, BARABE TIMOTHY C bought $206K and sold $0 based on SEC Form 4 filings.
What was BARABE TIMOTHY C's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 30,000 RNAC shares on 2025-12-04, worth $206K, per SEC Form 4 filings.